All SMSNA News

New research suggests that oral drugs for erectile dysfunction (ED) don’t increase a man’s risk for biochemical recurrence of prostate cancer. The term “biochemical recurrence” refers to the possibility that prostate cancer has come back after treatment. This occurs when a PSA (prostate-specific antigen) test shows that PSA levels have increased. Elevated PSA levels are not always a sign of...
Study: ED Drugs Don’t Increase Risk for Prostate Cancer Recurrence
Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.

You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Subscribe for our Newsletter!

Image